Clinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)

Condition:   Peripheral T Cell Lymphoma Intervention:   Biological: GB226 Sponsor:   Genor Biopharma Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials